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Abstract
Determining the cause of intraocular inflammation has important implications both
for the treatment and prognosis of uveitic diseases. This chapter describes ocular di‐
agnostic procedures and their indications while mainly focusing on diagnostic vi‐
trectomy. The chapter discusses the history of elective diagnostic procedures; main
indications for invasive procedures in the diagnosis of uveitic disease; surgical prin‐
ciples and techniques for each of the diagnostic procedures; descriptions of the vari‐
ous laboratory techniques being used; and selected examples of conditions that may
require the use of such techniques.
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1. Introduction
The term uveitis refers to a large and varied group of disease entities, each with its own set of
manifestations. While some may fit textbook characteristics, others may present in a way that
baffles us as clinicians and leaves us with a wide differential diagnosis. Determining the cause
of intraocular inflammation has important implications both for treatment and for prognosis
of the disease. That is where the field of invasive diagnostic procedures comes into place.
Through the use of different laboratory techniques, this diagnostic modality adds to the battery
of other methods available to the clinician in order to reach the final diagnosis and provide
proper management.
This chapter covers ocular diagnostic procedures, while focusing mainly on diagnostic
vitrectomy.
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
2. History
The earliest attempts at elective pars plana vitreous surgery were directed toward cutting
opaque vitreous. While still not used for the diagnosis of the etiology, papers as early as the
19th century report on the procedure in the context of ocular inflammation. Bull reported in
1890 on 17 cases in which a pars plana approach (first introduced by Von Graefe in 1863)
involving a discission needle introduced through the pars plana was used to cut vitreous
membranes resulting from inflammation or hemorrhage. [1]
The 1970s were a period of major advancement in the field of pars plana vitrectomy (PPV),
with the introduction of advanced instrumentation, such as the vitreous-infusion-suction-
cutter (VISC). Indications for diagnostic procedures and the diagnostic methods themselves
were limited at that time. In a review paper from 1974, Michels et al. [1] described vitreous
biopsy as a procedure that is rarely needed, with the most frequent indications being mycotic
endophthalmitis and reticulum cell sarcoma. The diagnostic methods that were mentioned
included only cytology and culture. Vitrectomy for endophthalmitis was also mentioned in
this paper, and showed that performing the procedure for this entity was a novelty.
One of the first papers to describe diagnostic vitrectomy was published by Engel et al in 1981.
[2] Findings resulting from early procedures in that era included ocular tumors such as
reticulum cell sarcoma and leukemic infiltration, as well as infectious entities such as fungal
endophthalmitis and acute retinal necrosis (ARN). The methods described there included
cytology, histopathology, and ultrastructural studies, with “new” methods such as using a
millipore filter and celloidin-bag cell-block techniques.
Since these early days, the field of diagnostic procedures has advanced rapidly. Methods
including polymerase chain reaction (PCR), flow cytometry, and other advanced methods
introduced in the general field of medicine have been adopted by ophthalmologists for use in
ocular diagnostic procedures. With the introduction of these methods, the list of etiologies that
can be recognized by invasive diagnostic techniques has also expanded, as will be described
here.
3. Indications
Accurate diagnosis of the etiology behind intraocular inflammation is essential in order to
provide the proper treatment and management and for prognostic reasons. While the general
approach to uveitis patients includes history taking, review of systems, examination, and
ancillary tests, at times none of these result in a conclusive diagnosis. In these atypical cases a
diagnostic vitrectomy may lead to the correct diagnosis. An example for such an indication is
primary intraocular lymphoma (PIOL), which requires a definitive tissue diagnosis to
diagnose and commence treatment.[3]
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Another indication for this procedure is failure of conventional therapy. While this might result
from an intractable disease, it may also be the result of a misdiagnosis, requiring an invasive
approach to reach the correct diagnosis.
A third indication is a sight-threatening disease, where the disease rapidity necessitates an
invasive approach for diagnosis, and at times also for treatment. Examples for infectious
entities that correspond to this description include infectious endophthalmitis [4] and ARN. [5]
4. Surgical principles and techniques
Prior to the procedures described henceforth, an informed consent should be obtained from
the patient after discussing the potential for complications. Since modern diagnostic techni‐
ques may require special preparation (e.g. special stains or cultures) the laboratory or pathol‐
ogist should be notified of the procedure and upcoming samples, and any requirements
regarding the handling of the sample prior to delivery should be noted.
4.1. Anterior chamber tap
Unlike diagnostic vitrectomy, an anterior chamber tap may be done in an office setting and is
less invasive. It is important to note that this procedure yields a smaller amount of fluid for
analysis in comparison with diagnostic vitrectomy, and as such may be considered in cases in
which a small sample may suffice for diagnosis.
The procedure is done under an aseptic technique. The area around the eye is cleaned with
povidone-iodine and a local anesthetic is instilled into the eye. It may be done at the slit lamp
or with the patient in a supine position by using binocular loupes. The eye is opened and fixated
with a speculum. The conjunctival surface is washed with povidone-iodine solution. A 27-30-
gauge needle on a tuberculin syringe is inserted to the anterior chamber using a limbal
approach, and 200 to 250 µL of fluid can be obtained. At the end of the procedure, an antibiotic
drop and povidone-iodine solution is instilled into the eye and a broad spectrum antibiotic
drop is prescribed for several days. [6, 7]
Anterior chamber tap is a relatively safe procedure. Possible complications include trauma to
the cornea, lens, and iris; hyphema; corneal abscess; and endophthalmitis. However these
complications are rare. [7]
4.2. Vitreous aspiration needle tap
A vitreous specimen for analysis can be obtained by straight needle vitreous aspiration, or
vitreous tap. This procedure has the advantages of being easier to perform, being less traumatic
to the eye than diagnostic vitrectomy, and offering the ability to perform it in an office setting.
Disadvantages of vitreous aspiration include: (1) the risk for retinal detachment from vitreor‐
etinal traction during aspiration [8]; (2) a smaller amount of specimen in comparison to
diagnostic vitrectomy as the procedure only yields about 300 µL of ocular fluid [9], which
allows for fewer diagnostic tests and possibly a lower yield; (3) it is also not therapeutic, as a
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diagnostic vitrectomy could be, since it does not clear a large amount of vitreous (and thus
does not allow for better diffusion of intraocular medications, [10] removal of pathogens or
improved media clarity [11, 12]).
The procedure is done under an aseptic technique. The area around the eye is cleaned with
povidone-iodine and a local anesthetic is instilled into the eye. The eye is opened and fixated
with a speculum and the conjunctival surface is washed with povidone-iodine solution. A
large-caliber needle is usually needed, such as a 21-gauge hollow needle, mounted on a 1 ml
syringe as an aspirating device, which permits better control during the procedure. The needle
is directed posteriorly in the direction of the optic nerve head and vitreous humor is obtained.
At the end of the procedure an antibiotic drop and povidone-iodine solution is instilled into
the eye, and a broad spectrum antibiotic drop is prescribed for several days. [9]
4.3. Diagnostic vitrectomy
The aim of vitrectomy is to try to obtain the maximum possible amount of tissue from which
a diagnosis can be made. A small sample volume may reduce the diagnostic yield. A variety
of techniques involving the use of 20, 23, and 25 G PPV have been described in the literature.
[13-19] An undiluted vitreous sample is obtained using a 3 or 5 mL syringe attached to the
vitreous cutter. When the vitrector is cutting the vitreous, the assistant manually aspirates it
until the eye softens, and the infusion is turned on. This provides between 1-2 mL of undiluted
vitreous. Some authors propose using continuous infusion of air or perfluorocarbon liquid to
substitute the vitreous removed from the eyeball which allows obtaining a larger amount of
vitreous. [20, 21]
Following collection of undiluted specimen, fluid infusion is initiated and a second syringe
is placed on the vitreous cutter to collect 3-10 mL of a diluted vitreous sample. [11, 15, 18]
The  surgeon  may  then  proceed  with  core  vitrectomy,  induction  of  a  posterior  vitreous
detachment, and peripheral vitrectomy using a standard approach if necessary. [16, 19, 21]
Meticulous peripheral vitrectomy in the presence of significant media opacity, as may occur
in many uveitis patients, is accompanied by potential complications and should generally
be avoided. [21]
Complications
Diagnostic vitrectomy carries the possibility of complications encountered in vitrectomy for
other indications, with some added due to the nature of the underlying etiology.
Cataract formation is a common complication after vitrectomy procedures reported to range
from 12.5%-80% in 20-gauge PPV and 22.7%-79.3% in small gauge PPV. [22] The rate of cataract
progression is higher in individuals older than 50 years. [23]
Retinal detachment is a possible complication of any PPV. In the setting of diagnostic vitrec‐
tomy, this complication may be related to the underlying etiology. For example, in cases of
viral or fungal endophthalmitis it may already appear at the time of surgery, complicating the
diagnostic procedure. [24]
Advances in Eye Surgery166
Retinal detachment may also occur as a result of surgery. Iatrogenic retinal tears at the time of
surgery may lead to retinal detachment. [25] This complication is especially true in ARN, where
necrosis of the retina leads to its atrophy and subsequent retinal break formation. [26] It also
may occur due to the development of new retinal breaks postoperatively.
Other, rarer complications of PPV include open-angle glaucoma, [27] retinal and vitreous
incarceration, endophthalmitis, and vitreous hemorrhage. [28]
4.4. Chorioretinal biopsy
Chorioretinal biopsy should only be considered when the inflammatory process is localized
primarily in the sensory retina, retinal pigment epithelium, or choroid and when in a previous
workup neither aqueous nor vitreous samples provided the diagnostic answer. The main
indication is diagnosis of a suspected intraocular lymphoma.
It is important to remember that this procedure involves a greater risk, including subretinal
hemorrhage, vitreous hemorrhage, and retinal detachment, [29, 30] and should therefore only
be used as a last resort.
The procedure may be done using 20 or 23 G 3-port PPV. Prior to the biopsy, undiluted and
diluted vitreous samples are collected as described previously. The vitreous is separated over
the biopsy site and intraocular diathermy is used to delineate the biopsy site and the border
between the lesion and normal retina. A sample size of 1 x 1 mm or 2 x 2 mm is excised using
vertical scissors or a diamond blade, while elevating the intraocular pressure temporarily to
70-90 mm Hg to prevent bleeding. The tissue is then grasped using intraocular forceps and
removed through the sclerotomy site. Endolaser is applied around the biopsy site and the
procedure is ended with long-acting gas or silicone tamponade. [21]
5. Diagnostic testing of vitreous specimens
With the advent of new laboratory techniques, a myriad of options are available for the
clinician in the quest for obtaining a correct diagnosis of an unknown inflammatory, infectious,
or neoplastic entity.
Of course not all tests should be performed in all cases, and tests should be chosen according
to the suspected diagnosis.
5.1. Histopathologic evaluation
A sample is sent to a pathologist following the diagnostic procedure and is immediately
processed. The specimen is generally divided into three portions: one third is fixed for routine
histopathological evaluation, including light and electron microscopic examination. Another
one third is frozen in optimal cutting temperature (OCT) embedding compound for immu‐
nopathology (phenotyping of cells by their surface markers) and molecular characterization.
The last third portion is sent for culture of microorganisms. If the specimen is not adequate for
Diagnostic Procedures in Ophthalmology
http://dx.doi.org/10.5772/60484
167
all three procedures, frozen sections are recommended, as they can undergo routine histopa‐
thology, immunohistochemistry, and molecular analysis. [20]
5.2. Cytology
Cytological evaluation reveals the phenotypes of infiltrating cells in the vitreous. The vitreous
specimen is centrifuged and cells are smeared onto glass slides, and then immersed in 95%
ethanol for Papanicolaou (Pap) staining or left to dry for Giemsa staining. [20]
The reported sensitivity of cytology in the detection of intraocular malignancy ranges from
31% to 66.7%. This relatively low yield may be due to the presence of immune cells, necrotic
cells, fibrin, and debris in the specimen, which may confound the examination. [31] Other
reasons include small sample volumes with a low number of malignant cells, inadequate
preparation of the sample, and previous administration of corticosteroids. [20]
Cytologic evaluation may also be used to distinguish between a malignant process and an
inflammatory disease. An example of an inflammatory etiology that may be diagnosed with
the aid of cytology is sarcoidosis. Kinoshita et al. demonstrated multinucleated giant cells in
the vitreous in 85.7% of cases and lymphocytes and epithelioid cells in all cases of intraocular
sarcoidosis. [32]
An advanced technique for cytology is the use of cell blocks. They are superior to cell smears
since cells are accumulated by centrifugation and stored as paraffin blocks. The large number
of cells in a compacted area of one section on a slide glass as opposed to sparse cells on a smear
leads to a more accurate diagnosis. Paraffin sections also have the advantage of being used for
immunocytochemical diagnosis and clonal analysis, such as amplification by PCR of the
immunoglobulin heavy chain gene. [33]
5.3. Microbiological analysis
Microbiological cultures are considered the “gold standard” for diagnosis of infectious uveitis.
There are different types of media for isolation of the causative agent, including blood agar
(for gram-positive or fastidious gram-negative bacteria [34]), MacConkey agar (for most gram-
negative rods [34]), and Brucella agar for bacterial infections; Sabouraud dextrose agar for
pathogenic fungi and yeast; and shell vial culture for viral infections. Along with the culture,
the sample is sent for Gram staining and antibiotic sensitivity tests. [20]
Some fastidious organisms, such as Proprionibacterium acnes and fungi require holding the
culture for at least 1 month to avoid missing their diagnosis. [21]
The sensitivity of culture after diagnostic vitrectomy for diagnosis of chronic infectious uveitis
has been reported between 16.7% and 96%. [21] In cases of acute endophthalmitis, the
sensitivity of microbiological cultures and stains was shown to be 40-70%. [35] Higher yields
are reported with vitreous rather than aqueous samples. [36] Processing both diluted and
undiluted vitreous samples increases the sensitivity of vitreous cultures to 57.4%. [37]
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The yield of positive cultures from vitreous samples is usually low in cases of fungal endoph‐
thalmitis. In a retrospective study by Tanaka et al., positive cultures were only found in 38%
of vitreous specimens in patients with endogenous fungal endophthalmitis. [38]
While the utility of Gram stains is limited in comparison with culture (data from the Endoph‐
thalmitis Vitrectomy Study showed a yield of 66% for culture and 41% for Gram stain for
patients undergoing vitrectomy [35]), they are useful for rapid initial diagnosis of intraocular
infection and can help the clinician choose the appropriate antibiotic for the organism prior to
culture results.
5.4. Molecular analysis
Molecular analysis of a vitreous specimen is used for two main indications: 1) to diagnose
PIOL 2) to detect the DNA of microorganisms in cases of infectious uveitis.
The techniques currently in use for molecular analysis include PCR, an in vitro technique used
to amplify small quantities of nucleic acid into analytic amounts [39] and microdissection,
which allows the selection and molecular analysis of malignant or atypical lymphoid cells from
vitreous samples with a small amount of preserved cells. [31]
In cases of infectious uveitis, several PCR techniques may be used. Over the years new
modifications to the basic method, such as real-time PCR and multiplex PCR have been
developed. Real-time PCR allows for the characterization of an active infection versus low-
grade pathogenicity by quantifying the number of pathogen genomes in a sample. Multiplex
PCR allows for the amplification and detection of a number of different sequences at the same
time (such as two infectious agents from a single sample). [40]
The addition of PCR to microbiological analysis has been shown to increase the diagnostic
sensitivity from 48% to more than 80%. [41] Prior short-term use of intravitreal antibiotics does
not affect its ability to amplify DNA. In one series of patients with postoperative endophthal‐
mits treated with intravitreal antibiotics, PCR of vitreal specimens identified the causative
organism in 10 of 16 patients (62%) versus only 3 (18%) with culture only. [42]
As the causative organism is not always known or suspected, a PCR technique that targets a
specific microorganism is not always feasible. In such cases eubacterial PCR may be used. It
targets the 16S ribosomal DNA (rRNA) common to all bacteria, thereby identifying a wider
range of pathogens. [42-44] A similar approach detects the fungal genome in ocular fluids using
probes that target the 18S rRNA present in the Candida and Aspergillus species, and probes that
target the 28S rRNA also found in other species, including Cryptococcus, Trichophyton, Mucor,
Penicillium, and Pichia. [45]
For PIOL diagnosis, PCR is used to detect monoclonality within the variable region of the third
complementary determining region (CDR3) in the immunoglobulin heavy chain gene of
malignant B cells. Single-band detection of immunoglobulin heavy chain rearrangement can
be useful in PIOL. [20] In a study by Baehring et al., PCR was 64% sensitive for PIOL and
identified immunoglobulin heavy chain gene rearrangements in four samples that were
classified as negative for lymphoma based on cytopathology and flow cytometry. Cytology
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had 24% sensitivity and flow cytometry had a sensitivity of 36%. [46] In addition, PCR may be
used to detect bcl-2 gene translocations in PIOL that were shown to occur in younger patients,
suggesting a more aggressive treatment approach. [47]
5.5. Flow cytometry
Flow cytometry is a diagnostic technique that allows for simultaneous analysis of several
different cell surface markers. It involves centrifuging diluted vitreous and re-suspension in
cell culture medium. The cells are then counted and stained with antibodies to detect cellular
surface markers that identify leukocytes. [20]
It has been shown to be useful in the diagnosis of PIOL. [16] It relies on the fact that most PIOLs
are composed of monoclonal populations of B-lymphocytes that stain positively for B cell
markers (CD19, CD20, CD22) and have restricted expression of κ or λ chains [48]
Davis et al [49] correlated different flow cytometric markers with lymphoma, infection, and
idiopathic uveitis. They found that the most sensitive marker for lymphoma was a κ:λ ratio
≥3 or ≤0.6, while CD22 and CD20 were specific but not sensitive for lymphoma. For infection
they found that the CD8, CD14, and CD11c markers that indicate monocytes and cytotoxic
CD8+ T lymphocytes were specific, but not sensitive. A CD4:CD8 ratio of ≥4 was highly
sensitive and specific for inflammatory uveitis.
5.6. Cytokine measurement
B-cell malignancies can secrete high levels of interleukin-10 (IL-10), an immunosuppressive
cytokine. Inflammatory conditions are associated with high levels of interleukin-6 (IL-6), a
proinflammatory cytokine. [50, 51] IL-10 in PIOL tends to be high, with IL-10:IL-6 ratios greater
than 1.0 being suggestive of the disease. This ratio may serve as a useful adjunctive test in the
diagnosis of suspected PIOL, while also showing whether there is a significant response to
treatment. [31]
Cassoux et al [52] found that mean IL-10 values were 2205.5 pg/mL in the vitreous and 543.4
pg/mL in the aqueous humor in patients with PIOL, while in uveitis patients mean values were
26.6 pg/mL in the vitreous and 21.9 pg/mL in the aqueous. This difference was highly signif‐
icant.
Since the measurement of cytokine levels is fairly easy, measurement of IL-10 and IL-6 levels
is recommended for patients with suspected PIOL. [20]
5.7. Antibody measurement
This indirect method of diagnosing infection is often negative early in the course of the disease
as well as in immunocompromised patients. [31] Intraocular-specific antibody secretion has
been shown to confirm the etiology in 23-32% of cases. [53, 54]
A helpful concept in antibody measurement is the Goldmann-Witmer coefficient (GWC). It
can be calculated to compare intraocular antibody production with serum antibody levels. A
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ratio of greater than 1.0 is abnormal and ratios of 2-3 are considered significant. [55] Its accuracy
has been shown in the case of toxoplasmosis. [56] Errera et al have shown that GWC testing
had better sensitivity than PCR in ocular toxoplasmosis, especially when the test was carried
out in younger patients with quiet eyes, with smaller sized chorioretinal lesions. In contrast,
they have shown that this test was not helpful in viral retinitis in comparison to PCR, as the
sensitivity and positive predictive value (PPV) were lower for GWC. [57]
6. Selected examples
6.1. Infectious etiologies
6.1.1. Bacterial and fungal endophthalmitis
In cases of suspected bacterial or fungal endophthalmitis, Gram stain and culture (aerobic,
anerobic, and fungal) of the vitreous sample are performed in order to identify the causative
organisms and their susceptibilities.
As mentioned above, PCR analysis of aqueous and vitreous fluid have also been applied in
case series of patients with acute and delayed postoperative endophthalmitis, sometimes with
better detection of the causative agent than cultures.
6.1.2. Mycobacterium tuberculosis
Diagnosis of ocular tuberculosis (TB) is possible with the use of various tests for the detection
of systemic TB, including chest radiography, Purified Protein Derivative (PPD) tuberculin skin
test, Interferon Gamma Release assays (IGRA), and analyses of extraocular sites. [58, 59]
Intraocular fluid analysis may help.
Traditional fluid analysis with Ziehl-Neelsen staining and culture on Lowenstein-Jensen
medium is not ideal, as the former has low yields and the latter takes up to 6-8 weeks, limiting
its clinical utility. [58, 59] The yield of PCR analysis of aqueous and vitreous fluid has been
shown to range from 37.7% to 72% in a series of Indian patients. [60-62] It was shown that
77-80% of PCR-positive patients in these series were PPD positive, and 90-100% of PCR-
positive patients who were treated with antitubercular treatment had resolution of inflamma‐
tion. Similar rates were shown by a Mexican group, [63] where PCR testing in 22 patients with
a known diagnosis of TB uveitis showed a yield of 77.2%. All patients improved with antitu‐
bercular treatment.
6.1.3. Toxoplasma gondii
While diagnosis of ocular toxoplasmosis is typically made by a characteristic clinical presen‐
tation and supported by positive serology, there are cases that pose a diagnostic dilemma in
which an invasive ocular diagnostic procedure may be needed. For example, in immunocom‐
promised and elderly patients the disease may mimic viral necrotizing retinitis. [64, 65]
Diagnostic Procedures in Ophthalmology
http://dx.doi.org/10.5772/60484
171
Culture of T. gondii from the vitreous may be lengthy and ranges from 2 to 23 days for positive
cultures. [66] The rapid detection of toxoplasmosis DNA using PCR techniques on aqueous
fluid has a yield of 13% to 55% according to literature, with positive results occurring more
often with larger chorioretinal lesions, immunosuppressed patients, and active anterior
segment inflammation. [21] Antibody levels in the aqueous may supplement PCR results by
calculating the GWC, as described above. In one series, calculation of the aqueous GWC for
toxoplasmosis antibody at the onset of clinical manifestation had a yield of 57%, rising to 70%
after 3 weeks. [67]
The utility of GWC is decreased in immunocompromised patients. In one series of 34 immu‐
nocompetent patients with negative PCR tests for toxoplasmosis, 25 had a positive GWC,
whereas none of the immunocompromised patients exhibited a positive test. [56] In a similar
fashion, another series showed 93% positivity with use of this test in immunocompetent
patients, in comparison with a yield of only 57% in immunocompromised patients. [68]
While these results deal with aqueous analysis, less data appears in the literature regarding
diagnostic vitrectomy for this purpose. Available data shows a trend towards improved yields
for PCR from vitreous specimens. [21]
6.1.4. Viral retinitis
The diagnosis of infectious viral retinitis caused by herpes simplex virus (HSV), cytomegalo‐
virus (CMV), or varicella zoster virus (VZV) is not always straightforward. As with the other
infectious entities just mentioned, growth on culture may take a long time. PCR analysis of
aqueous and vitreous fluid plays an important role thanks to its high sensitivity, low false-
positive rates, and the rapidity of the assay. [69, 70]
The  sensitivities  of  PCR  for  VZV,  HSV,  and  CMV  were  reported  to  exceed  90%,  with
specificities in excess of 95%. [39] Knox et al. performed PCR on specimens from 38 eyes
of  37  patients  with  an  inflammation  of  unknown  etiology  suggestive  of  an  infectious
posterior  segment  disease.  In  24  of  these  cases  CMV, HSV,  or  VZV were detected.  [71]
Sugita et al. collected 68 aqueous humor samples and 43 vitreous fluid samples from 100
patients  with uveitis.  The samples were assayed for  human herpes viruses using multi‐
plex PCR and real-time PCR. Out of 16 patients with ARN, either HSV1, HSV2, or VZV
genomes were detected. In another 10 patients with anterior uveitis with iris atrophy, the
VZV genome was detected. Epstein-Barr virus was detected in 17% of samples, and (CMV)
was detected in three patients with anterior uveitis of immunocompetent patients and in
one immunocompromised CMV retinitis patient. [72]
As was shown above for toxoplasmosis, calculation of the GWC may also be of use for HSV,
VZV, and CMV, although variable results have been reported in the literature. In one series of
immunocompromised patients with posterior uveitis and panuveitis, analysis of an aqueous
sample demonstrated a detection rate of 94% for PCR aimed for the detection of CMV and
VZV versus only 18% with GWC. [73] Another series demonstrated an identification of 92%
of HSV-associated and 87.5% of VZV-associated infectious uveitis using GWC, in comparison
with 54% of HSV and 75% VZV cases that were identified using PCR. [74]
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6.2. Non-infectious inflammatory conditions
6.2.1. Sarcoidosis
The frequency of sarcoidosis involving the posterior segment varies in different series. One
group reported that as many as 89% of patients with ocular sarcoidosis demonstrated posterior
segment involvement, with vitritis as the most common manifestation, present in 69% of these
patients. [75] As the manifestations of sarcoidosis are varied, a diagnosis of this inflammatory
entity is not always straightforward, and may require an invasive procedure such as diagnostic
pars plana vitrectomy.
An increased CD4+ helper T-cell type 1 lymphocyte subset in bronchoalveolar lavage (BAL)
fluid and a high CD4/CD8 ratio are helpful for the diagnosis of sarcoidosis. [76] Kojima et al.
demonstrated that this ratio may also be applied for vitreous specimens, when a CD4/CD8
ratio of vitreous-infiltrating lymphocytes greater than 3.5 provided a diagnosis of ocular
sarcoidosis with a sensitivity of 100% and a specificity of 96.3% (in comparison with a sensi‐
tivity of 53% and specificity of 94% in analysis of BAL fluid). [77]
6.3. Neoplastic processes
6.3.1. Primary intraocular lymphoma
PIOL is considered one of the masquerade syndromes, or diseases that mimic inflammatory
conditions in presentation, leading to a diagnostic dilemma. [78] When the diagnosis of a
neoplastic process such as PIOL is suspected, reaching a diagnosis is of utmost importance in
terms of prognosis and the choice of treatment.
A definitive tissue diagnosis is required to make the diagnosis of PIOL. If lymphoma is
identified from a lumbar puncture, an invasive diagnostic ocular procedure may not be
required. If, on the other hand, lumbar puncture results are inconclusive and neuroimaging is
not consistent with CNS lymphoma in a patient with a high index of suspicion for PIOL,
invasive diagnostic procedures are appropriate. [3]
Histologic identification of malignant lymphoid cells is the gold standard for diagnosing PIOL.
[3] As stated above, it is pertinent to communicate with the pathologist before the procedure,
as any delay in delivery of the sample may result in death of acquired cells.
The characteristic features of PIOL using microscopic analyses include large atypical lymphoid
cells with scarce cytoplasm, prominent nucleoli, frequently large segmented nuclei, and a high
nuclear to cytoplasm ratio. [3] Cytology has a sensitivity ranging from 31% to 66.7% for
detecting intraocular malignancy, and one report showed a sensitivity of 83.3% for detecting
PIOL. [31, 49] In addition to cytology, immunohistochemistry, cytokine analysis, flow
cytometry, and gene rearrangements by PCR are also performed on the specimens. [3]
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6.3.2. Tumor metastasis
Tumor metastasis is the most common cause of intraocular malignancy in adults. [78] While
their typical appearance and preexisting history of cancer typically lead to diagnosis, uveal
metastases masquerading as intraocular inflammation have been reported. [21]
A few cases were reported on the use of aqueous sampling for cytology which led to the
diagnosis of metastases masquerading as anterior uveitis. [79-84] Of patients undergoing
diagnostic vitrectomy for uveitis of unknown cause, detection of metastasis from cytology
results was rare in the literature, [11, 85, 86] with only one case reported in each of these series.
In case reports of patients with the rare occurrence of tumors metastatic to the retina and
vitreous, these conditions present as intermediate uveitis, vitreous hemorrhage, or retinal
vasculitis with vitreous cytology and retinal biopsy assisting in diagnosis if no primary
malignancy is identified. [21]
In a series of 159 cases by Shields et al, [87] transocular fine needle aspiration (FNA) biopsy
led to an adequate sample collection in 88% of cases, with a sensitivity rate of 100% and
specificity rate of 98%, leading to diagnosis of intraocular malignancies such as uveal mela‐
noma, uveal metastasis, retinoblastoma, lymphoma, and leukemia. In another series of 39
patients with uveal metastasis undergoing ocular biopsy of the tumor, 25 G vitrectomy had a
yield of 100% for cytologic diagnosis. It indicated the site of origin in 24 out of 27 patients
without a known primary tumor. [88]
7. Summary
Diagnostic procedures in ophthalmology have gone a long way from the early days of pars
plana vitrectomy, when instrumentation and diagnostic methods were limited and the amount
of entities that could be diagnosed by invasive methods was restricted.
As this chapter has shown, the approach to a patient with a cryptic diagnosis, a rapidly
deteriorating disease, or treatment failure has changed in the last decades and ophthalmolo‐
gists now have in their arsenal a battery of tools to help in the diagnosis of cases that were once
considered unsolvable or untreatable.
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